We are live on ! Find out more

2,057 hedge funds and large institutions have $142B invested in Merck in 2018 Q3 according to their latest regulatory filings, with 117 funds opening new positions, 756 increasing their positions, 900 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more first-time investments, than exits

New positions opened: 117 | Existing positions closed: 61

25% more call options, than puts

Call options by funds: $1.4B | Put options by funds: $1.12B

24% more funds holding in top 10

Funds holding in top 10: 115143 (+28)

18% more capital invested

Capital invested by funds: $120B → $142B (+$21.5B)

2% more funds holding

Funds holding: 2,0182,057 (+39)

1.27% more ownership

Funds ownership: 77.38%78.66% (+1.3%)

16% less repeat investments, than reductions

Existing positions increased: 756 | Existing positions reduced: 900

Holders
2,057
Holders Change
+39
Holders Change %
+1.93%
% of All Funds
47.02%
Holding in Top 10
143
Holding in Top 10 Change
+28
Holding in Top 10 Change %
+24.35%
% of All Funds
3.27%
New
117
Increased
756
Reduced
900
Closed
61
Calls
$1.4B
Puts
$1.12B
Net Calls
+$284M
Net Calls Change
+$173M
Name Holding Trade Value Shares
Change
Change in
Stake
CIM
1326
CIM Investment Management
Pennsylvania
$1.03M -$121K -1,894 -11%
PFM
1327
Parsec Financial Management
North Carolina
$1.03M +$27.6K +434 +3%
BAM
1328
Belpointe Asset Management
Nevada
$1.03M +$430K +6,756 +80%
BDF
1329
Balasa Dinverno & Foltz
$1.03M +$82.7K +1,298 +9%
LC
1330
Lourd Capital
California
$1.03M +$19.4K +305 +2%
PC
1331
Port Capital
Illinois
$1.03M +$968K +15,188 New
FIM
1332
Freedom Investment Management
Connecticut
$1.02M +$49.3K +774 +5%
SFM
1333
Signet Financial Management
New Jersey
$1.02M -$16.9K -265 -2%
ADBIC
1334
A.D. Beadell Investment Counsel
Wisconsin
$1.02M -$66.6K -1,045 -6%
NHC
1335
Nicholas Hoffman & Company
Georgia
$1.02M +$45.5K +714 +5%
TBNY
1336
Trustco Bank (New York)
New York
$1.01M
LCM
1337
Leisure Capital Management
California
$1.01M +$36.1K +567 +4%
AWM
1338
Altavista Wealth Management
North Carolina
$1.01M
SAM
1339
Shikiar Asset Management
New York
$1.01M
ACI
1340
Alpha Cubed Investments
California
$1.01M +$316K +4,960 +52%
WP
1341
WMS Partners
Maryland
$1M -$3.76K -59 -0.4%
TFF
1342
The Family Firm
Maryland
$1M -$15.9K -249 -2%
UF
1343
Univest Financial
Pennsylvania
$998K -$55K -863 -6%
SXL
1344
Summit X LLC
Missouri
$997K -$85.4K -1,341 -8%
EFSCE
1345
Enterprise Financial Services Corp (EFSC)
Missouri
$996K -$254K -3,980 -21%
BPCE
1346
Bank Pictet & Cie (Europe)
Germany
$995K
WWM
1347
Windsor Wealth Management
Indiana
$994K +$523K +8,212 +127%
HC
1348
Hampstead Capital
United Kingdom
$993K
JCM
1349
Jacobi Capital Management
Pennsylvania
$988K +$31.7K +497 +4%
VC
1350
Vicus Capital
Pennsylvania
$986K -$21K -329 -2%

MRK Hedge Fund Activity: Q3 2018 in Review

2,057 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2018, worth a combined $142B — up 18% from $120B a quarter earlier.

Buyers outnumbered sellers: 117 funds opened new MRK positions and 61 closed out — a net gain of 56 holders — while 756 added to existing stakes and 900 trimmed.

The largest buyer was Capital International Investors, adding an estimated $1.41B. The largest seller was Capital World Investors, cutting an estimated $1.18B.

  • 2,057 institutional investors held Merck (MRK) as of Q3 2018, up from 2,018 in Q2 2018.
  • Funds reported $142B of Merck stock for Q3 2018, up 18% quarter-over-quarter.
  • 117 funds opened new Merck positions in Q3 2018 and 61 closed out, a net change of +56 holders.
  • The largest Merck buyer in Q3 2018 was Capital International Investors, an estimated $1.41B added.
  • The largest Merck seller in Q3 2018 was Capital World Investors, an estimated $1.18B sold.

Based on aggregated 13F filings for Q3 2018.